Table 1.
Variables | PCOS n = 61 |
CONTROL n = 35 |
p-Value |
---|---|---|---|
Age (years) | 0.125 | ||
median (25–75%) | 16 (15–17) | 15 (15–17) | |
Body height (m) | 0.876 | ||
mean(sd) | 166.2(6.09) | 166.4(6.17) | |
Body weight (kg) | 0.159 | ||
median (25–75%) | 62.3 (52.8–77.5) | 56.9 (53.25–62.25) | |
BMI categories | 0.001 | ||
Underweight | 2 (3.28%) | 0 | |
Healthy weight | 37 (60.66%) | 34 (97.14%) | |
Overweight/Obesity | 22 (36.07%) | 1 (2.86%) | |
IL-1 (pg/mL) | 0.116 | ||
median (25–75%) | 24.7 (18.93–32.35) | 22.75 (15.09–29.87) | |
IL-6 (ng/L) | 0.189 | ||
median (25–75%) | 28.15 (22.72–36.89) | 24.33 (18.19–43.15) | |
TNF-α (ng/L) | 0.313 | ||
median (25–75%) | 74.54 (56.37–107.8) | 85.16 (64.8–98.2) | |
CRP (mg/L) | 0.010 | ||
median (25–75%) | 0.71 (0.35–1.3) | 0.41 (0.28–0.58) | |
TC (mg/dL) | 0.096 | ||
median (25–75%) | 158 (135.2–174.4) | 145.3 (125.6–165.4) | |
LDL-C (mg/dL) | 0.013 | ||
median (25–75%) | 80.3 (64.3–98.2) | 65.4 (57.6–81.15) | |
HDL-C (mg/dL) | 55.42(10.4) | 58.27(14.07) | 0.300 |
mean(sd) | |||
TG (mg/dl) | 0.228 | ||
median (25–75%) | 84.5 (66.7–117.4) | 75.6 (58.05–106.45) | |
Fasting glucose (mmol/L) | 0.942 | ||
median (25–75%) | 88.1 (84.48–92.5) | 90.4 (81.75–93.75) | |
Fasting insulin (mU/mL) | 0.002 | ||
median (25–75%) | 14.36 (9.35–19.11) | 9.74 (7.73–13.06) | |
HOMA-IR | 0.006 | ||
median (25–75%) | 2.94 (1.87–4.36) | 2.24 (1.64–2.8) | |
WC (cm) | <0.001 | ||
median (25–75%) | 76 (68–87) | 65.5 (64.25–67) |
Abbreviations: PCOS, polycystic ovary syndrome; IL-1-interleukin-1; IL-6-interleukin-6; TNF-α-Tumor Necrosis Factor α; CRP-C-reactive protein; TC-total cholesterol; LDL-C—low-density lipoprotein cholesterol; HDL-C—high-density lipoprotein cholesterol; TG-triglycerides; HOMA-IR-Homeostatic Model Assessment of Insulin Resistance; WC—Waist Circumference. All the p-values marked in bold were statistically significant.